ZEISS Group, a privately owned company headquartered in Germany, was founded in 1846, employs approximately 38,770 individuals, and reported $13.4B in revenue as of 2025. The company's primary product is content acquisition, functioning as a tier 3 media tech buyer. ZEISS operates in the fields of optics and optoelectronics, with segments including Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology, and Consumer Markets.
International patients chose Korea's SNU Eye Clinic for advanced SMILE Pro surgery, utilizing the ZEISS VisuMax 800 laser platform, which enables vision correction treatment in approximately seven seconds to support greater precision, comfort, and efficiency. Earlier on August 6, Carl Zeiss Meditec reported revenue of approximately €1553.7 million for the first nine months of fiscal year 2025/26, a 2.9% decline from the prior year, though stable at 0.0% when adjusted for currency effects. During this period, the Ophthalmology strategic business unit (SBU) experienced a revenue decline of 4.8% to €1191.4 million. Baden-Württemberg State Premier Cem Özdemir also visited the ZEISS site in Oberkochen on August 4, 2026. Previously, on August 5, ZEISS Ventures led a €2.2 million investment round in SeeTrue Technologies, a Finnish deep-tech company, to accelerate the commercialization of its ultra-low-power eye-sensing architecture for next-generation interfaces in smart optical systems and eyewear.
Similar Companies
Subscribe for full access to ZEISS Group's profile
ZEISS Group offers products in the media tech industry. ZEISS Group's product portfolio comprises of content acquisition.
Subscribe for full access to ZEISS Group's products in full detail
ZEISS Group's revenues were over $1B in 2025. All the revenue comes from camera lenses.
Subscribe for full access to ZEISS Group's revenue in full detail
Subscribe for full access to ZEISS Group's products in full detail 
